PTK6 and prostate carcinoma: In human prostate cancer, increased expression of PTK6, its relocation from the nucleus to the cytoplasm, and subsequent activation at the plasma membrane facilitate the phosphorylation and activation of substrates like AKT, p130CAS, and FAK, thereby fostering cancer advancement (20).